Craneware: trading in-line
Craneware (LON: CRW), the market leader in Value Cycle solutions for the US healthcare market, commented on a strong performance for its first half ending 31 December 2020.
Increased sales momentum resulted in growth at both the revenue and adjusted EBITDA levels of greater than 5% compared to the first half of the prior year (HY20 Revenue: $35.9m, adjusted EBITDA $12.7m).
The Group's customer retention rate has remained above 90% and the dollar…
Sign up and read the full article
Register to continue reading our content.
Get FREE access now
Already a member? Login
Previous article
Next article
More on Bonhill Group
09/06/2023 · Company Insights
Reassuring interim results, expertise in AI and news of share buy-backs has lifted the shares of…
24/05/2023 · Company Insights
The valuations of two companies covered in our free update here are tough to assess and…
More on Craneware
16/09/2025 · Company Insights
The results are coming thick and fast and there are some crackers covered here, dispelling the…
18/07/2025 · Company Insights
Hot on the heels of its first acquisition, a retailer of fresh cream cakes is chancing…
More on Mission Group
25/10/2023 · Company Insights
News covered in our free update here includes an unexpected profit warning from a communications agency…
29/09/2023 · Company Insights
News covered here includes our thoughts on results from several modestly valued companies from the marketing…
More on Mortgage Advice Bureau
22/05/2025 · Company Insights
News covered here includes our assessment of interim results from a very high-quality company. We consider…
04/02/2025 · Company Insights
News covered in the update here includes our assessment of impressive results from one of our…
More Company Insights
Telematics group is flying - more to go for?
Medical device company is the standout here
Plenty of fast-growing UK companies to enjoy
More on Bonhill Group
More on Craneware
More on Mission Group
More on Mortgage Advice Bureau
More Company Insights